Voyageur Pharmaceuticals Ltd.
VYYRF
$0.08
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.83% | 34.79% | -145.72% | 32.24% | -71.41% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.41% | -148.38% | -14.99% | -28.26% | 2,291.47% |
| Change in Net Operating Assets | -28.71% | 225.54% | 10,461.54% | 99.70% | -216.86% |
| Cash from Operations | 54.30% | 58.84% | -247.30% | 74.21% | -3,309.38% |
| Capital Expenditure | 70.86% | 21.45% | -474.66% | 50.68% | -15.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 70.86% | 21.45% | -474.66% | 50.68% | -15.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.22% | 1,709.09% | -94.40% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -230.28% | 1.15% | -5.14% | -139.58% |
| Cash from Financing | -- | -113.46% | 7,651.70% | -98.64% | 789.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.03% | -217.63% | 322.18% | -156.02% | 180.10% |